U.S. High Growth Tech and AI Stocks

AVITA Medical

Market Cap: US$266.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Alnylam Pharmaceuticals

Market Cap: US$32.6b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Ascendis Pharma

Market Cap: US$9.9b

A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Travere Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Lumentum Holdings

Market Cap: US$4.1b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

TG Therapeutics

Market Cap: US$6.6b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Alkami Technology

Market Cap: US$2.8b

Provides cloud-based digital banking solutions in the United States.

Arcutis Biotherapeutics

Market Cap: US$1.7b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Super Micro Computer

Market Cap: US$21.6b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Clene

Market Cap: US$25.9m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Alvotech

Market Cap: US$2.4b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Legend Biotech

Market Cap: US$6.3b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Blueprint Medicines

Market Cap: US$5.6b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Applied Optoelectronics

Market Cap: US$631.1m

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

Core Scientific

Market Cap: US$2.5b

Provides digital asset mining services in the United States.

Palantir Technologies

Market Cap: US$264.5b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Bitdeer Technologies Group

Market Cap: US$2.1b

Operates as a technology company for blockchain and computing.

CoreWeave

Market Cap: US$19.3b

Operates a cloud platform that provides scaling, support, and acceleration for GenAI.

Red Cat Holdings

Market Cap: US$469.7m

Provides various products, services, and solutions to the drone industry in the United States.

MeiraGTx Holdings

Market Cap: US$528.3m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

SpringWorks Therapeutics

Market Cap: US$3.4b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

Checkpoint Therapeutics

Market Cap: US$343.4m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

SideChannel

Market Cap: US$9.2m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

Aldeyra Therapeutics

Market Cap: US$158.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Soleno Therapeutics

Market Cap: US$3.4b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Silence Therapeutics

Market Cap: US$158.7m

A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

TruGolf Holdings

Market Cap: US$9.8m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.

Duos Technologies Group

Market Cap: US$77.1m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

Roadzen

Market Cap: US$67.7m

Operates as an insurance technology company.

ARS Pharmaceuticals

Market Cap: US$1.4b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Vanda Pharmaceuticals

Market Cap: US$247.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

UroGen Pharma

Market Cap: US$455.0m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

OS Therapies

Market Cap: US$34.7m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

RenovoRx

Market Cap: US$36.2m

A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

Abeona Therapeutics

Market Cap: US$258.7m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Madrigal Pharmaceuticals

Market Cap: US$7.2b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.